R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells

Given that glioma stem cells (GSCs) play a critical role in the initiation and chemoresistance in glioblastoma multiforme (GBM), targeting GSCs is an attractive strategy to treat GBM. Utilizing an anti-cancer compound library, we identified R406, the active metabolite of a FDA-approved Syk inhibitor...

詳細記述

保存先:
書誌詳細
出版年:Cell Death Dis
主要な著者: Sun, Shuxin, Xue, Dongdong, Chen, Zhijie, Ou-yang, Ying, Zhang, Ji, Mai, Jialuo, Gu, Jiayv, Lu, Wanjun, Liu, Xincheng, Liu, Wenfeng, Sheng, Longxiang, Lu, Bingzheng, Lin, Yuan, Xing, Fan, Chen, Zhongping, Mou, Yonggao, Yan, Guangmei, Zhu, Wenbo, Sai, Ke
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494878/
https://ncbi.nlm.nih.gov/pubmed/31043589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1587-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料